CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-06 | Hayden Michael R Director | Option exercise · Stock Option (right to buy) | −270,000 | 540,000 | ||
| 2020-10-29 | Lecault Veronique Chief Operating Officer | Grant or award · Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2020-10-29 | Stimart Tryn Chief Legal Officer | Grant or award · Stock Option (right to buy) | +850,000 | 850,000 |
Page 11 of 11 · 203 trades